on June 30, 2005
Published online before print June 30, 2005, doi: 10.1161/01.ATV.0000175750.94742.46
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 29, 2005
Accepted on June 16, 2005
Identification and Characterization of Vascular Calcification-Associated Factor, a Novel Gene Upregulated During Vascular Calcification In Vitro and In Vivo
M. Yvonne Alexander *;
From the Cardiovascular Research Group (M.Y.A., F.L.W., J.P.K., G.D.M.C., A.M.H., A.E.C.), Department of Medicine and Endocrine Science; Wellcome Trust Centre for Cell-Matrix Research (J.P.K., C.F.R., G.D.M.C., A.E.C.); Department of Laboratory and Regenerative Medicine (M.J.); and Department of Vascular Surgery (J.V.S.), University of Manchester, United Kingdom.
* To whom correspondence should be addressed. E-mail: yvonne.alexander{at}manchester.ac.uk.
Objective-- Vascular calcification, with its increasing clinical sequelae, presents an important and unresolved dilemma in cardiac and vascular practice. We aimed to identify molecules involved in this process to develop strategies for treatment or prevention.
Methods and Results--Using subtractive hybridization, a novel cDNA, designated vascular calcification-associated factor (VCAF), has been isolated from a bovine retinal pericyte cDNA library generated during the differentiation and mineralization of these cells in vitro. RNA ligase-mediated rapid amplification of cDNA ends was used to compile the 740-bp bovine cDNA sequence. Database searching reveals that VCAF has novel nucleotide/amino acid sequences. RNA analysis confirms that VCAF is upregulated in mineralized pericytes and is present in human calcified arteries but not noncalcified arteries. Protein analysis using a VCAF antipeptide antibody confirms the presence of an 18-kDa protein in calcified nodules but not in confluent pericytes. Adenoviral antisense VCAF gene delivery reduces VCAF protein levels and accelerates pericyte differentiation compared with controls.
Conclusion--We demonstrate the isolation of a novel gene, VCAF, which is upregulated during vascular calcification in vitro and in vivo. Antisense VCAF gene delivery accelerates pericyte differentiation, implicating a role for VCAF in this clinically significant pathological process.
Key words: atherosclerosis • genes • pericytes • calcification • novel gene
This article has been cited by other articles:
 |
|
 |
|
  K. A. Johnson, M. Polewski, and R. A. Terkeltaub Transglutaminase 2 Is Central to Induction of the Arterial Calcification Program by Smooth Muscle Cells Circ. Res., March 14, 2008; 102(5): 529 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D.M. Collett, A. P. Sage, J. P. Kirton, M. Y. Alexander, A. P. Gilmore, and A. E. Canfield Axl/Phosphatidylinositol 3-Kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells Circ. Res., March 2, 2007; 100(4): 502 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Kirton, F. L. Wilkinson, A. E. Canfield, and M. Y. Alexander Dexamethasone Downregulates Calcification-Inhibitor Molecules and Accelerates Osteogenic Differentiation of Vascular Pericytes: Implications for Vascular Calcification Circ. Res., May 26, 2006; 98(10): 1264 - 1272. [Abstract] [Full Text] [PDF]
|
|